Eli Lilly will start selling its Covid-19 antibody treatment to states, hospitals and other healthcare providers as the federal government’s supply runs low. The company will charge $2,100 for each dose.
Biden administration, drug maker in talks to ensure bebtelovimab remains available to people without health insurance
Since the start of the Covid-19 pandemic in 2020, the scientific understanding of its transmission and prevention has evolved. WSJ’s Daniela Hernandez explains what strategies have worked for stemming the spread of the virus and which are outdated in 2022. Illustration: Adele Morgan
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
New Numbers Show More Californians are Getting Reinfected With COVID-19According to the new state health department numbers last month, at least 50,000 people came down with COVID for a second time.
Weiterlesen »
ADPH shifting strategies in COVID-19 responseADPH says it will begin shifting from an emergency response to one that minimizes the daily disruptions of Alabamians’ everyday lives.
Weiterlesen »
Long Beach now offering Novavax COVID-19 vaccineLong Beach is now offering the Novavax vaccine for COVID-19. Here's why some might find it preferable to Moderna or Pfizer.
Weiterlesen »
A first update on mapping the human genetic architecture of COVID-19 - NatureMatters arising: A first update on mapping the human genetic architecture of COVID-19
Weiterlesen »
Seahawks head coach Pete Carroll tests positive for COVID-19Seattle Seahawks head coach Pete Carroll has tested positive for COVID-19, the team announced on Monday. FOX13
Weiterlesen »
What to Do If Your Child Gets COVID-19 Between ShotsPediatricians say that getting COVID-19 in between doses should not significantly alter a child’s vaccination schedule
Weiterlesen »